⌘K

Home/Filings/4/0001815776-24-000046

4//SEC Filing

Chevallard Daniel R. 4

Accession 0001815776-24-000046

CIK 0001815776other

View on SEC.gov Company Profile

Filed

May 14, 8:00 PM ET

Accepted

May 15, 4:13 PM ET

Size

4.7 KB

Accession

0001815776-24-000046

Insider Transaction Report

Form 4

Period: 2024-05-14

LENZ Therapeutics, Inc.LENZ

Chevallard Daniel R.

Chief Financial Officer

Transactions

Purchase
Common Stock
2024-05-14$15.68/sh+3,188$49,988→ 3,188 total

Documents

1 file

4
wk-form4_1715803974.xmlPrimary
FORM 4

Issuer

LENZ Therapeutics, Inc.

CIK 0001815776

Entity typeother

Related Parties

1

filerCIK 0001706176

Filing Metadata

Form type: 4
Filed: May 14, 8:00 PM ET
Accepted: May 15, 4:13 PM ET
Size: 4.7 KB

View on SEC.gov